In the “Lightning Round” segment, Jim Cramer enthusiastically answers viewer stock questions, highlighting strong prospects for Wave Quantum and Palantir, while expressing caution on overvalued stocks like Idex. He predicts a potential quick gain for Palantir based on upcoming major deals and shares personal insights on investing strategies and specific stocks.
In the video, Jim Cramer hosts a lively “Lightning Round” segment where viewers call in with stock questions. He begins with enthusiasm, highlighting the rapid-fire nature of the segment and encouraging callers to share their investment queries. The segment features a mix of stock analyses, personal anecdotes, and Cramer’s signature energetic commentary.
One caller from Pennsylvania asks about the stock Wave Quantum (ticker D), which has shown impressive revenue growth and beat last year’s figures in just one quarter. Cramer responds positively, calling it the best among its peers and suggesting that if it continues to have good news, its stock could rise to $25. This indicates his bullish outlook on the company’s strong performance and growth potential.
Another caller from Maine mentions Idex, which has experienced a significant run-up. Cramer expresses skepticism, noting that the stock’s high valuation—42 times earnings—is too steep for his comfort. He declines to recommend it, emphasizing his cautious approach to stocks that are already heavily appreciated and may be due for a correction.
A caller from California asks about Palantir (ticker BBA), and Cramer deviates from the original plan to recommend it over the caller’s current holdings. He predicts that Palantir’s CEO, Alex Karp, will announce a major deal, which could lead to a quick 10-point gain. Cramer’s enthusiasm for Palantir reflects his belief in the company’s potential for big news and upward movement driven by hype and strategic announcements.
The segment concludes with a caller from South Carolina thanking Cramer for his advice, recalling how his guidance on buying stocks in small increments during dips helped diversify his portfolio. Cramer discusses Biohaven, which has underperformed despite positive analyst days, and admits to a personal deal with the company, which influences his opinion. The segment wraps up with a humorous exchange and a reminder that the Lightning Round is sponsored by Charles Schwab, followed by a teaser about Cramer’s upcoming insights on US chipmakers operating in China.